Margot Schoenborn is the CEO of OmniSeq, a Buffalo-based biotech company changing the way cancer is diagnosed. She stops by the podcast to discuss the Buffalo Niagara Medical Campus and our growing life sciences industry.
Tags: Bell Ringer
Margot Schoenborn is the CEO of OmniSeq, a Buffalo-based biotech company changing the way cancer is diagnosed. She stops by the podcast to discuss the Buffalo Niagara Medical Campus and our growing life sciences industry.
Invest Buffalo Niagara
257 W. Genesee St.
Buffalo, New York, 14202
1-800-916-9073
fax: 716-842-1724